- Home
- ABSI vs NEWT Comparison
ABSI vs NEWT Comparison
Compare ABSI & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$2.30
Company Overview
Basic Information| Metric | ABSI | NEWT |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.9M | 395.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABSI | NEWT |
|---|---|---|
| Price | $2.30 | $11.73 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | $7.98 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 2.5M | 162.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.34% |
| EPS Growth | ★ 21.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,534,000.00 | N/A |
| Revenue This Year | $10.72 | N/A |
| Revenue Next Year | $313.07 | $12.45 |
| P/E Ratio | ★ N/A | $5.99 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.01 | $9.12 |
| 52 Week High | $5.23 | $14.91 |
Technical Indicators
Market Signals| Indicator | ABSI | NEWT |
|---|---|---|
| Relative Strength Index (RSI) | 36.45 | 35.60 |
| Support Level | N/A | $11.72 |
| Resistance Level | $2.88 | $12.41 |
| Average True Range (ATR) | 0.16 | 0.47 |
| MACD | -0.01 | -0.08 |
| Stochastic Oscillator | 7.26 | 15.17 |
Price Performance
Historical Comparison ABSI
NEWT
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.